Clinical Trial

A Phase II, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo In Patient With Non-Alcoholic Steatohepatitis

Study Status:

Open For Enrollment

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This study will evaluate the efficacy, safety, and pharmacokinetics of BFKB8488A compared with placebo in patients with non-alcoholic steatohepatitis (NASH).

Information:

Principal Investigator	Fernando Membreno, MD
Sponsor	Genentech, Inc.
Type of Trial	Interventional

Contact Us For More Info Or To Apply

5323 S. McColl Rd., Edinburg, TX 78539

[email protected]

(956) 362-2390

Clinical Trial

A Phase II, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo In Patient With Non-Alcoholic Steatohepatitis

Study Status:

Study Purpose:

Information:

Useful Links

For Research Participants

About Us

News & Views